XI'AN, CHINA -- (MARKET WIRE) -- December 20, 2006 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today reported revenue and earnings guidance for both fourth quarter and full year 2006, ending December 31.
